These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16185887)

  • 41. Analysis of the subunit organization of the eIF2B complex reveals new insights into its structure and regulation.
    Wortham NC; Martinez M; Gordiyenko Y; Robinson CV; Proud CG
    FASEB J; 2014 May; 28(5):2225-37. PubMed ID: 24532666
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vanishing white matter: deregulated integrated stress response as therapy target.
    Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Moon SL; Parker R
    RNA; 2018 Jun; 24(6):841-852. PubMed ID: 29632131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity.
    Richardson JP; Mohammad SS; Pavitt GD
    Mol Cell Biol; 2004 Mar; 24(6):2352-63. PubMed ID: 14993275
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of eukaryotic initiation factor 2B in vitro by heat shock.
    Scheper GC; Thomas AA; van Wijk R
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):463-7. PubMed ID: 9716506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy.
    Takano K; Tsuyusaki Y; Sato M; Takagi M; Anzai R; Okuda M; Iai M; Yamashita S; Okabe T; Aida N; Tsurusaki Y; Saitsu H; Matsumoto N; Osaka H
    Brain Dev; 2015 Jun; 37(6):638-42. PubMed ID: 25457085
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [CACH/VWM syndrome and leucodystrophies related to EIF2B mutations].
    Labauge P; Fogli A; Niel F; Rodriguez D; Boespflug-Tanguy O
    Rev Neurol (Paris); 2007 Sep; 163(8-9):793-9. PubMed ID: 17878805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
    Kashiwagi K; Ito T; Yokoyama S
    Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coping with stress: eIF2 kinases and translational control.
    Wek RC; Jiang HY; Anthony TG
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):7-11. PubMed ID: 16246168
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The ovarioleukodystrophy.
    Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
    Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
    Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders.
    Horzinski L; Huyghe A; Cardoso MC; Gonthier C; Ouchchane L; Schiffmann R; Blanc P; Boespflug-Tanguy O; Fogli A
    PLoS One; 2009 Dec; 4(12):e8318. PubMed ID: 20016818
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severity of vanishing white matter disease does not correlate with deficits in eIF2B activity or the integrity of eIF2B complexes.
    Liu R; van der Lei HD; Wang X; Wortham NC; Tang H; van Berkel CG; Mufunde TA; Huang W; van der Knaap MS; Scheper GC; Proud CG
    Hum Mutat; 2011 Sep; 32(9):1036-45. PubMed ID: 21560189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
    Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
    Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy.
    Dietrich J; Lacagnina M; Gass D; Richfield E; Mayer-Pröschel M; Noble M; Torres C; Pröschel C
    Nat Med; 2005 Mar; 11(3):277-83. PubMed ID: 15723074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genotype-phenotype correlation in vanishing white matter disease.
    van der Lei HD; van Berkel CG; van Wieringen WN; Brenner C; Feigenbaum A; Mercimek-Mahmutoglu S; Philippart M; Tatli B; Wassmer E; Scheper GC; van der Knaap MS
    Neurology; 2010 Oct; 75(17):1555-9. PubMed ID: 20975056
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Astrocytes are central in the pathomechanisms of vanishing white matter.
    Dooves S; Bugiani M; Postma NL; Polder E; Land N; Horan ST; van Deijk AL; van de Kreeke A; Jacobs G; Vuong C; Klooster J; Kamermans M; Wortel J; Loos M; Wisse LE; Scheper GC; Abbink TE; Heine VM; van der Knaap MS
    J Clin Invest; 2016 Apr; 126(4):1512-24. PubMed ID: 26974157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver.
    Wisse LE; Visser D; Ter Braak TJ; Bakkali A; Struys EA; Morrison CD; van der Knaap MS; Abbink TEM
    Nutr Neurosci; 2022 Jun; 25(6):1219-1230. PubMed ID: 33236691
    [No Abstract]   [Full Text] [Related]  

  • 59. The N-terminal lysine residue-rich domain II and the 340-430 amino acid segment of eukaryotic initiation factor 2-associated glycoprotein p67 are the binding sites for the gamma-subunit of eIF2.
    Ghosh A; Datta R; Majumdar A; Bhattacharya M; Datta B
    Exp Cell Res; 2006 Oct; 312(16):3184-203. PubMed ID: 16857189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human-induced pluripotent stem cell-derived cerebral organoid of leukoencephalopathy with vanishing white matter.
    Deng J; Zhang J; Gao K; Zhou L; Jiang Y; Wang J; Wu Y
    CNS Neurosci Ther; 2023 Apr; 29(4):1049-1066. PubMed ID: 36650674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.